H.R.1504 - Vaccines for the New Millennium Act of 2001107th Congress (2001-2002)
|Sponsor:||Rep. Pelosi, Nancy [D-CA-8] (Introduced 04/04/2001)|
|Committees:||House - Ways and Means; Energy and Commerce; International Relations|
|Latest Action:||House - 04/25/2001 Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.1504 — 107th Congress (2001-2002)All Information (Except Text)
Vaccines for the New Millennium Act of 2001 - Amends the Internal Revenue Code to allow a limited business credit for the costs medical research related to developing vaccines against widespread diseases. Defines widespread diseases as malaria, tuberculosis, HIV, or any infectious disease (of a single etiology) which, according to the World Health Organization, causes over one million human deaths annually.
Introduced in House (04/04/2001)
Allows a limited lifesaving vaccine sale credit equal to the amount of qualified vaccine sales. Defines qualified vaccine sales as the aggregate amount paid to the taxpayer for a qualified sale. Defines a qualified sale as a sale of a qualified vaccine: (1) to a nonprofit organization or to a government of any foreign country (or instrumentality of such a government); and (2) for distribution in a developing country.
Establishes the Lifesaving Vaccine Purchase Fund.
Expresses the sense of Congress concerning the manufacture, distribution, support for global efforts, and tiered pricing of vaccines.